CIK 0000943819
- Large accelerated filer
RESMED INC
Sign in to watch- Tickers
- RMD RSMDF
- Exchange
- NYSE, OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 980152841
- Phone
- +1 858-746-2400
- Business address
- 9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, 92123
Securities
- RMD ResMed Inc. Common Stock NYSE
- RSMDF Common stock OTC
- 4 Planned sale Chief Financial Officer sold 1,000 shares at $233.47 ($233,470)
- 4 Planned sale Chief Executive Officer sold 14,683 shares at $231.91 ($3,405,206)
- 4 Planned sale Director sold 2,000 shares at $237.20 ($474,400)
- 4 Planned sale Chief Commercial Officer, SaaS sold 5,000 shares at $252.56 ($1,262,800)
- 4 Planned sale Chief Financial Officer sold 1,000 shares at $246.42 ($246,420)
- 4 Planned sale Chief Executive Officer sold 14,683 shares at $248.38 ($3,646,950)
- 4 Planned sale Director sold 2,000 shares at $239.90 ($479,800)
- 4 Grant or award Director acquired 267 shares (grant or award)
- 4 Planned sale Global General Counsel sold 882 shares at $231.00 ($203,742)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Financial Officer acquired 8,756 shares (grant or award)
- 4 Grant or award Global General Counsel acquired 4,950 shares (grant or award)
- 4 Grant or award Chief Product Officer acquired 9,137 shares (grant or award)
- 4 Grant or award President, SaaS Business acquired 8,756 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 23,370 shares (grant or award)
- 4 Planned sale President, SaaS Business sold 10,000 shares at $216.60 ($2,166,000)
- 4 Planned sale Chief Financial Officer sold 1,000 shares at $212.16 ($212,160)
- 4 Planned sale Chief Executive Officer sold 14,683 shares at $214.25 ($3,145,905)
- 4 Open-market sale President, Asia Latin America sold 48,000 shares at $217.07 ($10,419,552)
- 4 Planned sale Chief Executive Officer sold 14,683 shares at $192.97 ($2,833,330)
Page 8 of 92 · 1,833 filings